4.7 Article

Canakinumab reverses overexpression of inflammatory response genes in tumour necrosis factor receptor-associated periodic syndrome

Related references

Note: Only part of the references are listed.
Article Rheumatology

Treatment of autoinflammatory diseases: results from the Eurofever Registry and a literature review

Nienke ter Haar et al.

ANNALS OF THE RHEUMATIC DISEASES (2013)

Article Rheumatology

Autophagy contributes to inflammation in patients with TNFR-associated periodic syndrome (TRAPS)

Tiziana Bachetti et al.

ANNALS OF THE RHEUMATIC DISEASES (2013)

Article Rheumatology

Beyond the NLRP3 Inflammasome Autoinflammatory Diseases Reach Adolescence

Marco Gattorno et al.

ARTHRITIS AND RHEUMATISM (2013)

Review Cell Biology

Biological Treatments: New Weapons in the Management of Monogenic Autoinflammatory Disorders

Antonio Vitale et al.

MEDIATORS OF INFLAMMATION (2013)

Article Medicine, General & Internal

Two Randomized Trials of Canakinumab in Systemic Juvenile Idiopathic Arthritis

Nicolino Ruperto et al.

NEW ENGLAND JOURNAL OF MEDICINE (2012)

Review Medicine, Research & Experimental

Canakinumab

Eugen Dhimolea

Article Multidisciplinary Sciences

Concerted action of wild-type and mutant TNF receptors enhances inflammation in TNF receptor 1-associated periodic fever syndrome

Anna Simon et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)

Article Allergy

Autoinflammation: The prominent role of IL-1 in monogenic autoinflammatory diseases and implications for common illnesses

Raphaela Goldbach-Mansky et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2009)

Article Immunology

In vivo regulation of interleukin 1β in patients with cryopyrin-associated periodic syndromes

Helen J. Lachmann et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2009)

Review Rheumatology

Falling into TRAPS - receptor misfolding in the TNF receptor 1-associated periodic fever syndrome

Fiona C. Kimberley et al.

ARTHRITIS RESEARCH & THERAPY (2007)